Extraction-free protocol combining proteinase K and heat inactivation for detection of SARS-CoV-2 by RT-qPCR.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 16 10 2020
accepted: 12 02 2021
entrez: 26 2 2021
pubmed: 27 2 2021
medline: 10 3 2021
Statut: epublish

Résumé

Real-time reverse transcription PCR (RT-qPCR) is the gold-standard technique for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection in nasopharyngeal swabs specimens. The analysis by RT-qPCR usually requires a previous extraction step to obtain the purified viral RNA. Unfortunately, RNA extraction constitutes a bottleneck for early detection in many countries since it is expensive, time-consuming and depends on the availability of commercial kits. Here, we describe an extraction-free protocol for SARS-CoV-2 detection by RT-qPCR from nasopharyngeal swab clinical samples in saline solution. The method includes a treatment with proteinase K followed by heat inactivation (PK+HID method). We demonstrate that PK+HID improves the RT-qPCR performance in comparison to the heat-inactivation procedure. Moreover, we show that this extraction-free protocol can be combined with a variety of multiplexing RT-qPCR kits. The method combined with a multiplexing detection kit targeting N and ORF1ab viral genes showed a sensitivity of 0.99 and a specificity of 0.99 from the analysis of 106 positive and 106 negative clinical samples. In conclusion, PK+HID is a robust, fast and inexpensive procedure for extraction-free RT-qPCR determinations of SARS-CoV-2. The National Administration of Drugs, Foods and Medical Devices of Argentina has recently authorized the use of this method.

Identifiants

pubmed: 33635936
doi: 10.1371/journal.pone.0247792
pii: PONE-D-20-32588
pmc: PMC7909620
doi:

Substances chimiques

Endopeptidase K EC 3.4.21.64

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0247792

Déclaration de conflit d'intérêts

VG, MStortz, AW, BGB, PV, VD, FRL and VL participate in a Transfer Agreement between Facultad de Ciencias Exactas y Naturales (University of Buenos Aires), National Research Council –CONICET and Inbio Highway (Tandil, Argentina). This agreement was not signed yet at the moment of submission. MSalvatori declares no competing interest.

Références

Int J Infect Dis. 2020 Aug;97:66-68
pubmed: 32492531
J Clin Virol. 2020 Aug;129:104519
pubmed: 32629187
J Virol Methods. 2020 Dec;286:113965
pubmed: 32891677
PLoS Biol. 2020 Oct 2;18(10):e3000896
pubmed: 33006983
J Virol Methods. 2020 Nov;285:113960
pubmed: 32835738
Nat Microbiol. 2020 Oct;5(10):1299-1305
pubmed: 32651556
Acta Paediatr. 2007 Mar;96(3):338-41
pubmed: 17407452
medRxiv. 2020 Sep 17;:
pubmed: 32793925
J Clin Virol. 2020 Jul;128:104423
pubmed: 32416598
PLoS One. 2020 Jul 24;15(7):e0236564
pubmed: 32706827
Euro Surveill. 2020 Apr;25(14):
pubmed: 32290902
Int J Infect Dis. 2020 Oct;99:352-354
pubmed: 32791207
Nat Commun. 2020 Sep 23;11(1):4812
pubmed: 32968075
Nature. 2020 Jul;583(7817):506-509
pubmed: 32681157
Dis Markers. 2020 Dec 9;2020:8869424
pubmed: 33343767
Diagnostics (Basel). 2020 Aug 18;10(8):
pubmed: 32824767
Emerg Microbes Infect. 2020 Dec;9(1):1393-1396
pubmed: 32552549
J Clin Virol. 2020 Sep;130:104579
pubmed: 32795959
Ann Lab Med. 2016 Sep;36(5):457-62
pubmed: 27374711
J Clin Virol. 2020 Nov;132:104587
pubmed: 32898817
Lancet Infect Dis. 2020 Oct;20(10):1151-1160
pubmed: 32559451
J Clin Microbiol. 1995 Jan;33(1):41-4
pubmed: 7699063
J Med Virol. 2021 Jan;93(1):559-563
pubmed: 32779772
RNA. 2020 Jul;26(7):771-783
pubmed: 32358057
Nucleic Acids Res. 2009 Apr;37(6):e45
pubmed: 19237396

Auteurs

Valeria Genoud (V)

Facultad de Ciencias Exactas y Naturales, Departamento de Química Biológica, Universidad de Buenos Aires, Buenos Aires, Argentina.

Martin Stortz (M)

Facultad de Ciencias Exactas y Naturales, Departamento de Fisiología, Biología Molecular y Celular, Universidad de Buenos Aires, Buenos Aires, Argentina.
Facultad de Ciencias Exactas y Naturales, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.

Ariel Waisman (A)

LIAN-CONICET, FLENI, Belén de Escobar, Argentina.

Bruno G Berardino (BG)

Facultad de Ciencias Exactas y Naturales, Departamento de Química Biológica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Facultad de Ciencias Exactas y Naturales, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.

Paula Verneri (P)

Facultad de Ciencias Exactas y Naturales, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.

Virginia Dansey (V)

Facultad de Ciencias Exactas y Naturales, Departamento de Química Biológica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Facultad de Ciencias Exactas y Naturales, Unidad de Microanálisis y Métodos Físicos en Química Orgánica (UMYMFOR), CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.

Melina Salvatori (M)

Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.

Federico Remes Lenicov (F)

Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.

Valeria Levi (V)

Facultad de Ciencias Exactas y Naturales, Departamento de Química Biológica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Facultad de Ciencias Exactas y Naturales, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH